Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest

  • Authors:
    • Minyong Kang
    • Jin-Nyoung Ho
    • Ha Rim Kook
    • Sangchul Lee
    • Jong Jin Oh
    • Sung Kyu Hong
    • Sang Eun Lee
    • Seok-Soo Byun
  • View Affiliations

  • Published online on: December 29, 2015     https://doi.org/10.3892/or.2015.4537
  • Pages: 1463-1472
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the present study, we aimed to investigate the anticancer properties of Theracurmin®, a novel form of the yellow curry pigment curcumin, as well as explore the molecular mechanisms of the potential anticancer effects of Theracurmin® on human prostate cancer and bladder cancer cells in vitro. The proliferation of cancer cells was examined by using the Cell Counting Kit-8. The clonogenic growth potential was determined by clonogenic assay. Cell cycle distribution was evaluated by flow cytometry using propidium iodide staining. Western blot analysis was applied to explore the expression patterns of molecules associated with apoptotic cell death and cell cycle checkpoint. We noted that Theracurmin® and curcumin exhibited similar anticancer effects in both androgen-dependent and -independent human prostate cancer cells in a dose- and time-dependent manner. These agents reduced cell viability and clonogenic growth potential by inducing apoptosis and cell cycle disturbance in human prostate cancer cells. Theracurmin® and curcumin also exerted marked anticancer effects on human bladder cancer cells, even in cisplatin-resistant T24R2 cells, in a dose- and time-dependent manner. Moreover, Theracurmin® and curcumin treatment decreased cell viability and clonogenicity via induction of apoptotic cell death and cell cycle dysregulation in human bladder cancer cells. In conclusion, our study suggests that Theracurmin® has potential as an anticancer agent in complementary and alternative medicine for these urological cancers.
View Figures
View References

Related Articles

Journal Cover

March-2016
Volume 35 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kang M, Ho J, Kook HR, Lee S, Oh JJ, Hong SK, Lee SE and Byun S: Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest. Oncol Rep 35: 1463-1472, 2016.
APA
Kang, M., Ho, J., Kook, H.R., Lee, S., Oh, J.J., Hong, S.K. ... Byun, S. (2016). Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest. Oncology Reports, 35, 1463-1472. https://doi.org/10.3892/or.2015.4537
MLA
Kang, M., Ho, J., Kook, H. R., Lee, S., Oh, J. J., Hong, S. K., Lee, S. E., Byun, S."Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest". Oncology Reports 35.3 (2016): 1463-1472.
Chicago
Kang, M., Ho, J., Kook, H. R., Lee, S., Oh, J. J., Hong, S. K., Lee, S. E., Byun, S."Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest". Oncology Reports 35, no. 3 (2016): 1463-1472. https://doi.org/10.3892/or.2015.4537